Yuqi Zhao

Dr. Yuqi Zhao

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
DPDeanna L. Plubell
Deanna L. Plubell
PWPhillip A. Wilmarth
Phillip A. Wilmarth
YZYuqi Zhao
Yuqi Zhao
AFAlexandra M. Fenton
Alexandra M. Fenton
JMJessica Minnier
Jessica Minnier
NPNathalie Pamir
Nathalie Pamir
The lack of high-throughput methods to analyze the adipose tissue protein composition limits our understanding of the protein networks responsible for age and diet related metabolic response. We have developed an approach using multiple-dimension liquid chromatography tandem mass spectrometry and extended multiplexing (24 biological samples) with tandem mass tags (TMT) labeling to analyze proteomes of epididymal adipose tissues isolated from mice fed either low or high fat diet for a short or a long-term, and from mice that aged on low versus high fat diets. The peripheral metabolic health (as measured by body weight, adiposity, plasma fasting glucose, insulin, triglycerides, total cholesterol levels, and glucose and insulin tolerance tests) deteriorated with diet and advancing age, with long-term high fat diet exposure being the worst. In response to short-term high fat diet, 43 proteins representing lipid metabolism (e.g. AACS, ACOX1, ACLY) and red-ox pathways (e.g. CPD2, CYP2E, SOD3) were significantly altered (FDR < 10%). Long-term high fat diet significantly altered 55 proteins associated with immune response (e.g. IGTB2, IFIT3, LGALS1) and rennin angiotensin system (e.g. ENPEP, CMA1, CPA3, ANPEP). Age-related changes on low fat diet significantly altered only 18 proteins representing mainly urea cycle (e.g. OTC, ARG1, CPS1), and amino acid biosynthesis (e.g. GMT, AKR1C6). Surprisingly, high fat diet driven age-related changes culminated with alterations in 155 proteins involving primarily the urea cycle (e.g. ARG1, CPS1), immune response/complement activation (e.g. C3, C4b, C8, C9, CFB, CFH, FGA), extracellular remodeling (e.g. EFEMP1, FBN1, FBN2, LTBP4, FERMT2, ECM1, EMILIN2, ITIH3) and apoptosis (e.g. YAP1, HIP1, NDRG1, PRKCD, MUL1) pathways. Using our adipose tissue tailored approach we have identified both age-related and high fat diet specific proteomic signatures highlighting a pronounced involvement of arginine metabolism in response to advancing age, and branched chain amino acid metabolism in early response to high fat feeding. Data are available via ProteomeXchange with identifier PXD005953.

1 February 2017 in Cell Metabolism
Verified
Journal Article
Closed access
MSMoritz von Scheidt
Moritz von Scheidt
YZYuqi Zhao
Yuqi Zhao
ZKZeyneb Kurt
Zeyneb Kurt
CPCalvin Pan
Calvin Pan
LZLingyao Zeng
Lingyao Zeng
ALAldons J. Lusis
Aldons J. Lusis

1 January 2018 in Cell Systems
Verified
Journal Article
Closed access
KKKarthickeyan Chella Krishnan
Karthickeyan Chella Krishnan
ZKZeyneb Kurt
Zeyneb Kurt
RBRio Barrere-Cain
Rio Barrere-Cain
SSSimon Sabir
Simon Sabir
ADAditi Das
Aditi Das
XYXia Yang
Xia Yang

4 November 2016 in BMC Genomics
Verified
Journal Article
Open access
PDF file
LSLe Shu
Le Shu
YZYuqi Zhao
Yuqi Zhao
ZKZeyneb Kurt
Zeyneb Kurt
SBSean Geoffrey Byars
Sean Geoffrey Byars
TTTaru Tukiainen
Taru Tukiainen
XYXia Yang
Xia Yang
Complex diseases are characterized by multiple subtle perturbations to biological processes. New omics platforms can detect these perturbations, but translating the diverse molecular and statistical information into testable mechanistic hypotheses is challenging. Therefore, we set out to create a public tool that integrates these data across multiple datasets, platforms, study designs and species in order to detect the most promising targets for further mechanistic studies. We developed Mergeomics, a computational pipeline consisting of independent modules that 1) leverage multi-omics association data to identify biological processes that are perturbed in disease, and 2) overlay the disease-associated processes onto molecular interaction networks to pinpoint hubs as potential key regulators. Unlike existing tools that are mostly dedicated to specific data type or settings, the Mergeomics pipeline accepts and integrates datasets across platforms, data types and species. We optimized and evaluated the performance of Mergeomics using simulation and multiple independent datasets, and benchmarked the results against alternative methods. We also demonstrate the versatility of Mergeomics in two case studies that include genome-wide, epigenome-wide and transcriptome-wide datasets from human and mouse studies of total cholesterol and fasting glucose. In both cases, the Mergeomics pipeline provided statistical and contextual evidence to prioritize further investigations in the wet lab. The software implementation of Mergeomics is freely available as a Bioconductor R package. Mergeomics is a flexible and robust computational pipeline for multidimensional data integration. It outperforms existing tools, and is easily applicable to datasets from different studies, species and omics data types for the study of complex traits.

1 October 2015 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
IBIngrid Brænne
Ingrid Brænne
MCMete Civelek
Mete Civelek
Baiba VilneBaiba Vilne
Baiba Vilne
ANAntonio Di Narzo
Antonio Di Narzo
AJAndrew D. Johnson
Andrew D. Johnson
ALAldons J. Lusis
Aldons J. Lusis
Objective—: Genome-wide association studies have to date identified 159 significant and suggestive loci for coronary artery disease (CAD). We now report comprehensive bioinformatics analyses of sequence variation in these loci to predict candidate causal genes. Approach and Results—: All annotated genes in the loci were evaluated with respect to protein-coding single-nucleotide polymorphism and gene expression parameters. The latter included expression quantitative trait loci, tissue specificity, and miRNA binding. High priority candidate genes were further identified based on literature searches and our experimental data. We conclude that the great majority of causal variations affecting CAD risk occur in noncoding regions, with 41% affecting gene expression robustly versus 6% leading to amino acid changes. Many of these genes differed from the traditionally annotated genes, which was usually based on proximity to the lead single-nucleotide polymorphism. Indeed, we obtained evidence that genetic variants at CAD loci affect 98 genes which had not been linked to CAD previously. Conclusions—: Our results substantially revise the list of likely candidates for CAD and suggest that genome-wide association studies efforts in other diseases may benefit from similar bioinformatics analyses.

28 September 2017 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
LSLe Shu
Le Shu
K. H. Katie ChanK. H. Katie Chan
K. H. Katie Chan
GZGuanglin Zhang
Guanglin Zhang
THTianxiao Huan
Tianxiao Huan
ZKZeyneb Kurt
Zeyneb Kurt
XYXia Yang
Xia Yang
Cardiovascular diseases (CVD) and type 2 diabetes (T2D) are closely interrelated complex diseases likely sharing overlapping pathogenesis driven by aberrant activities in gene networks. However, the molecular circuitries underlying the pathogenic commonalities remain poorly understood. We sought to identify the shared gene networks and their key intervening drivers for both CVD and T2D by conducting a comprehensive integrative analysis driven by five multi-ethnic genome-wide association studies (GWAS) for CVD and T2D, expression quantitative trait loci (eQTLs), ENCODE, and tissue-specific gene network models (both co-expression and graphical models) from CVD and T2D relevant tissues. We identified pathways regulating the metabolism of lipids, glucose, and branched-chain amino acids, along with those governing oxidation, extracellular matrix, immune response, and neuronal system as shared pathogenic processes for both diseases. Further, we uncovered 15 key drivers including HMGCR, CAV1, IGF1 and PCOLCE, whose network neighbors collectively account for approximately 35% of known GWAS hits for CVD and 22% for T2D. Finally, we cross-validated the regulatory role of the top key drivers using in vitro siRNA knockdown, in vivo gene knockout, and two Hybrid Mouse Diversity Panels each comprised of >100 strains. Findings from this in-depth assessment of genetic and functional data from multiple human cohorts provide strong support that common sets of tissue-specific molecular networks drive the pathogenesis of both CVD and T2D across ethnicities and help prioritize new therapeutic avenues for both CVD and T2D. Cardiovascular disease (CVD) and type 2 diabetes (T2D) are two tightly interrelated diseases that are leading epidemics and causes of deaths around the world. Elucidating the mechanistic connections between the two diseases will offer critical insights for the development of novel therapeutic avenues to target both simultaneously. Because of the challenging complexity of CVD and T2D, involving numerous risk factors, multiple tissues, and multidimensional molecular alterations, few have attempted such an investigation. We herein report a comprehensive and in-depth data-driven assessment of the shared mechanisms between CVD and T2D by integrating genomics data from diverse human populations including African Americans, Caucasian Americans, and Hispanic Americans with tissue-specific functional genomics information. We identified shared pathways and gene networks informed by CVD and T2D genetic risks across populations, confirming the importance of well-established processes, as well as unraveling previously under-appreciated processes such as extracellular matrix, branched-chain amino acid metabolism, and neuronal system for both diseases. Further incorporation of tissue-specific regulatory networks pinpointed potential key regulators that orchestrate the biological processes shared between the two diseases, which were cross-validated using cell culture and mouse models. This study suggests potential new therapeutic targets that warrant further investigation for both CVD and T2D.